Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation

Sex-specific association of cardiovascular drug doses with adverse outcomes in atrial fibrillation

Objectives Sex differences occur in atrial fibrillation (AF), including age at first manifestation, pathophysiology, treatment allocation, complication rates and quality of life. However, optimal doses of cardiovascular pharmacotherapy used in women with AF with or without heart failure (HF) are unc...

Full description

Saved in:
Bibliographic Details
Main Authors: David Conen, Stefan Osswald, Tobias Reichlin, Michael Kuhne, Christine Baumgartner, Nicolas Rodondi, Richard Kobza, Giorgio Moschovitis, Carole Clair, Jeanne Moor, Carole Elodie Aubert, Angelo Auricchio, Juerg H Beer, Seraina Netzer, Leo Bonati
Format: Article
Language:English
Published: BMJ Publishing Group 2024-08-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/11/2/e002720.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://openheart.bmj.com/content/11/2/e002720.full

Similar Items